Search research articles
Contact Us
Filters
Showing results (221-230 of 750) with videos related to
Page
of 75
Sort By:
Journal of Clinical Medicine
|
April 27, 2024
Potential Therapeutic Targets in Obesity, Sleep Apnea, Diabetes, and Fatty Liver Disease
Christina Gu, Nicole Bernstein, Nikita Mittal, et al.
The American Journal of Gastroenterology
|
June 23, 2026
PREVALENCE AND RISK FACTORS ASSOCIATED WITH MASLD AND ADVANCED FIBROSIS AMONG OVERWEIGHT INDIVIDUALS: IMPLICATIONS FOR SCREENING GUIDELINES
Maria Mironova, Kaleb Tesfai, Egbert Madamba, et al.
Lancet (London, England)
|
August 23, 2025
Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Rohit Loomba, Erin Morgan, Keyvan Yousefi, et al.
Alimentary Pharmacology & Therapeutics
|
May 9, 2020
Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis
Björn Carlsson, Daniel Lindén, Gabriella Brolén, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 13, 2010
Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men
Rohit Loomba, Hwai-I Yang, Jun Su, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 29, 2024
Global Prevalence of Advanced Liver Fibrosis and Cirrhosis in the General Population: A Systematic Review and Meta-analysis
Mohammad Zamani, Shaghayegh Alizadeh-Tabari, Veeral Ajmera, et al.
Nature Reviews. Gastroenterology & Hepatology
|
May 12, 2018
The gut-liver axis and the intersection with the microbiome
Anupriya Tripathi, Justine Debelius, David A Brenner, et al.
Alimentary Pharmacology & Therapeutics
|
November 15, 2025
Gastrointestinal Cancer Risk in Steatotic Liver Diseases: MASLD, MetALD and ALD
Nobuharu Tamaki, Takefumi Kimura, Shun-Ichi Wakabayashi, et al.
Hepatology (Baltimore, Md.)
|
September 3, 2013
Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice
Ling Yang, Yoon Seok Roh, Jingyi Song, et al.
The Lancet. Oncology
|
June 2, 2022
Clinical features and outcomes of NAFLD-related hepatocellular carcinoma - Authors' reply
Darren Jun Hao Tan, Cheng Han Ng, Mark D Muthiah, et al.
Page
of 75
Search research articles
Search
Showing results (221-230 of 750) with videos related to
Sort By:
Page
of 75
Journal of Clinical Medicine
|
April 27, 2024
Potential Therapeutic Targets in Obesity, Sleep Apnea, Diabetes, and Fatty Liver Disease
Christina Gu, Nicole Bernstein, Nikita Mittal, et al.
The American Journal of Gastroenterology
|
June 23, 2026
PREVALENCE AND RISK FACTORS ASSOCIATED WITH MASLD AND ADVANCED FIBROSIS AMONG OVERWEIGHT INDIVIDUALS: IMPLICATIONS FOR SCREENING GUIDELINES
Maria Mironova, Kaleb Tesfai, Egbert Madamba, et al.
Lancet (London, England)
|
August 23, 2025
Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Rohit Loomba, Erin Morgan, Keyvan Yousefi, et al.
Alimentary Pharmacology & Therapeutics
|
May 9, 2020
Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis
Björn Carlsson, Daniel Lindén, Gabriella Brolén, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 13, 2010
Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men
Rohit Loomba, Hwai-I Yang, Jun Su, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 29, 2024
Global Prevalence of Advanced Liver Fibrosis and Cirrhosis in the General Population: A Systematic Review and Meta-analysis
Mohammad Zamani, Shaghayegh Alizadeh-Tabari, Veeral Ajmera, et al.
Nature Reviews. Gastroenterology & Hepatology
|
May 12, 2018
The gut-liver axis and the intersection with the microbiome
Anupriya Tripathi, Justine Debelius, David A Brenner, et al.
Alimentary Pharmacology & Therapeutics
|
November 15, 2025
Gastrointestinal Cancer Risk in Steatotic Liver Diseases: MASLD, MetALD and ALD
Nobuharu Tamaki, Takefumi Kimura, Shun-Ichi Wakabayashi, et al.
Hepatology (Baltimore, Md.)
|
September 3, 2013
Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice
Ling Yang, Yoon Seok Roh, Jingyi Song, et al.
The Lancet. Oncology
|
June 2, 2022
Clinical features and outcomes of NAFLD-related hepatocellular carcinoma - Authors' reply
Darren Jun Hao Tan, Cheng Han Ng, Mark D Muthiah, et al.
Page
of 75